CVM CEL-SCI Corp.: Market Capitalization to Book Value Ratio

This chart shows the market price for CEL-SCI Corporation (CVM) on the GURU.Markets platform as 2.53. The business relies on its authority in developing head and neck tumor treatments via immune activation. The absence of current sales eliminates any pricing power, while future profits depend on the proven efficacy of the therapy. High risks are associated with pressure from capital players conducting numerous parallel tests.

CEL-SCI Corporation automates the synthesis of immunotherapeutic agents via robotic bioreactors, eliminating human error. This technological superiority directly impacts the net asset value, establishing the foundation for business valuation. This metric compares the company's current market value with its book value. The gap between these figures signals either a market overvaluation or an undervaluation of assets. Analyzing the market-to-book ratio allows for the determination of investment stability boundaries.